Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAXX4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,593
Award facts
- Contract value 100% obligated
- $36,593.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $36,593.05 for DESCOVY 200-25 mg tablets (30-count units) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price, competitively awarded delivery order represents a purchase of pharmaceutical inventory to support federal medical supply needs. The award was issued with no set-aside designation, reflecting open competition in the procurement process. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this transaction.
This delivery order was issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle extending through December 2026 that provides comprehensive global pharmaceutical support to military and federal healthcare systems. The IDC enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen has demonstrated consistent capability to fulfill competitive federal supply requirements through its extensive portfolio of drug and medical supply deliveries to the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FAXX4?
SPE2DB25FAXX4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FAXX4 worth?
The government has obligated $36,593 on SPE2DB25FAXX4.
Is contract SPE2DB25FAXX4 an order under another contract?
Yes. SPE2DB25FAXX4 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAXX4 competed?
The extent of competition for SPE2DB25FAXX4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award